Pasar al contenido principal

EFECTOS DE FITOESTROGENOS PRESENTES EN DIETA Y ANALISIS DE POTENCIALES ADITIVOS PARA REDUCIR LA ADIPOSIDAD Y MEJORAR LA FUNCION INTESTINAL Y EL CRECIMIENTO EN TRUCHA Y DORADA

AGL2017-89436-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Regulation of gh expression in gilthead sea bream pituitary

  • Perelló-Amorós, Miguel
  • Sánchez-Moya, Albert
  • Moosavi, M.
  • Hoseinzade, M.
  • Hedayatirad, M.
  • Vélez, Emilio
  • Balbuena-Pecino, S.
  • Calduch-Giner, Josep A.
  • Pérez-Sánchez, Jaume
  • Capilla, E.
This is the 10th volume of Advances in Comparative Endocrinology, a series of books that collect the communications presented at the congresses of the Iberian Association for Comparative Endocrinology (AIEC). This round number marks roughly 20 years since the foundation of AIEC and the beginning of the biennial meetings organized by AIEC affiliated groups. In 2005, our Comparative Endocrinology and Integrative Biology group CEIB-CCMAR organized the 5th AIEC meeting and it was a pleasure to welcome the 12th AIEC Congress back again to Faro, Portugal, in 2019 (26-28 September). Volume X includes contributions resulting from plenary, keynote, oral or poster presentations, and authored by almost 150 senior or young scientists and students, which show the latest advances in the fields of reproduction, energy metabolism, genomics, evolution, stress, immune response and growth in both vertebrates and invertebrates. Studies range from fundamental questions on endocrinology to environmental challenges, animal production and welfare, or the mechanisms of disease, and reach beyond the Iberian borders. In addition to Portugal and Spain, the science presented here comes from institutions in Canada, Chile, France, Norway and USA. About 30% of the communications result from international cooperation, and over 55% were direct collaborations between institutions. AIEC aims to promote collaborations and its congresses are a privileged stage for networking., Supported by funds from the Ministerio de Ciencia, Innovación y Universidades (MICIUN) (AGL2017-89436-R and RTI2018- 100757-B-I00), 2017SGR-1574 and XRAq. M.P-A and S.B-P are recipients of a FPI fellowship from the MICIUN (BES-2016-078697 and PRE2018-085580 respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cysteamine improves growth and the GH/IGF axis in gilthead sea bream (Sparus aurata): in vivo and in vitro approaches

  • Sánchez-Moya, Albert
  • Balbuena-Pecino, S.
  • Vélez, Emilio
  • Perelló-Amorós, Miguel
  • García-Meilán, Irene
  • Fontanillas, Ramón
  • Calduch-Giner, Josep A.
  • Pérez-Sánchez, Jaume
  • Fernández-Borràs, Jaume
  • Blasco, Josefina
  • Gutiérrez, Joaquím
Aquaculture is the fastest-growing food production sector and nowadays provides more food than extractive fishing. Studies focused on the understanding of how teleost growth is regulated are essential to improve fish production. Cysteamine (CSH) is a novel feed additive that can improve growth through the modulation of the GH/IGF axis; however, the underlying mechanisms and the interaction between tissues are not well understood. This study aimed to investigate the effects of CSH inclusion in diets at 1.65 g/kg of feed for 9 weeks and 1.65 g/kg or 3.3 g/kg for 9 weeks more, on growth performance and the GH/IGF-1 axis in plasma, liver, stomach, and white muscle in gilthead sea bream (Sparus aurata) fingerlings (1.8 ± 0.03 g) and juveniles (14.46 ± 0.68 g). Additionally, the effects of CSH stimulation in primary cultured muscle cells for 4 days on cell viability and GH/IGF axis relative gene expression were evaluated. Results showed that CSH-1.65 improved growth performance by 16% and 26.7% after 9 and 18 weeks, respectively, while CSH-3.3 improved 32.3% after 18 weeks compared to control diet (0 g/kg). However, no significant differences were found between both experimental doses. CSH reduced the plasma levels of GH after 18 weeks and increased the IGF-1 ones after 9 and 18 weeks. Gene expression analysis revealed a significant upregulation of the ghr-1, different igf-1 splice variants, igf-2 and the downregulation of the igf-1ra and b, depending on the tissue and dose. Myocytes stimulated with 200 µM of CSH showed higher cell viability and mRNA levels of ghr1, igf-1b, igf-2 and igf-1rb compared to control (0 µM) in a similar way to white muscle. Overall, CSH improves growth and modulates the GH/IGF-1 axis in vivo and in vitro toward an anabolic status through different synergic ways, revealing CSH as a feasible candidate to be included in fish feed., This publication is part of the R+D+i projects AGL2015-70679-R and RTI2018-100757-B-I00 to JG and JB, and AGL2017-89436-R funded by the Spanish “Ministerio de Ciencia e Innovación” (MCIN/AEI/10.13039/501100011033/), the “Xarxa de Refèrencia d’R+D+I en Aqüicultura” (Aqüival Cist-Crec) and the 2017-SGR1574 from the “Generalitat de Catalunya”. SB-P, EV and MP-A, were funded by predoctoral fellowships from the MINECO grants PRE2018-085580, BES-2013-062949 and BES-2016-078697, respectively., Peer reviewed